Dr. Bonaventura Clotet, MD, PhD
Specialized in Internal Medicine and Infectious Diseases. PhD in Medical Sciences in 1981 (Incidence and clinical significance of anti-ENA antibodies in connective tissue diseases).
Dr. Bonaventura Clotet received his MD at the Universitat Autònoma de Barcelona in 1976 and his PhD in 1981 for his investigations on surrogate markers for connective tissue diseases.
He is Head of the HIV Unit since 1987 and Director of the Institute for AIDS Research IrsiCaixa at the University Hospital Germans Trias i Pujol, in Badalona, Barcelona, Spain since 1993. He is also President of the Foundation Lluita contra la Sida, founded in 1992. Since 2006, he is co-director of the HIVACAT programme for HIV Vaccine Research in Catalonia, Spain. Indeed, he is associated professor of Medicine at the Universitat Autonoma of Barcelona (UAB).
Dr. Clotet is member of the steering committee of EuroSIDA (multicenter group for the study of AIDS in Europe) since 1994 and his retrovirology laboratory at the Institute for AIDS Research IrsiCaixa is the reference lab for HIV resistance in Europe through EuroSIDA. He has been member of the Drug Resistance Mutations Group (IAS-USA) during 10 years, until July 2011 and of the Governing Council of the IAS during 8 years, until July 2010. He also participates in the organizing committee and scientific committee of several drug resistance workshops and international AIDS conferences; indeed, he is an active member of the Spanish Expert Commission for the Evaluation of Research projects in the National Programme of Health and national AIDS Programme. Dr. Clotet has been co-chair of Track B for the Barcelona World AIDS meeting 2002.
He has published more than 500 papers in international journals. He is member of the editorial board of AIDS Journal, HIV Medicine, Expert Review of Clinical Immunology, Future HIV therapy and Journal of the International Association of Physician in AIDS Care. He is reviewer for AIDS, JAIDS, JID, Antiviral Therapy, HIV Medicine, CID, Lancet, and Drugs.
Dr. Clotet was co-director (together with Dr. José M. Gatell) of Aids Cyberjournal (ACJ) integrated in Timely Topics in AIDS (TTM-sida Prous), from 1997 to 2006. Since 2007, he coordinates educasida with ACJ, offering continuous medical update about HIV & related diseases, and also providing free consult and advice to HIV infected patients.
Since 2009, he is a member of the Scientific Advisory Board Member of Fundació Príncep de Girona.
In October 2010 he was awarded by the Catalan Health Institute (ICS) for his lifetime scientific career.
Since 2011, he is the director of the Master in AIDS Pathogenesis and Treatment (Escoles Universitàries Gimbernat-UAB-IrsiCaixa).
In March 2012 he was the co-chair for the 10th European Meeting on HIV & Hepatitis held in Barcelona. In April 2012 he was the co-chair of the 13 International Workshops on Clinical Pharmacology of HIV Therapy held in Barcelona. In May, he organized (together with Charles Boucher, Wei He and Aikichi Iwamotto) the 1st Asian Conference on treatment of Viral Diseases in Beijing, China. In October, he was awarded by the Government of Catalonia (Generalitat de Catalunya) with the Josep Trueta medal to Sanitary Merit for his contributions to the research in the HIV field.
In April 2013, Dr. Bonaventura Clotet received the Honoris Causa award at the University Carol Davila in Bucharest (Romania) and the Honor Membership award of the Institut Medicofarmacèutic de Catalunya. In May, he organized the 2nd Asian Conference on Hepatitis and HIV in Beijing, China, together with Charles Boucher, We He, Taisheng Li, Stephan Locarnini, Jürgen Rockstroh, Jonathan Schapiro and Aikichi Iwamoto.
In October 2013, Dr. Clotet became member of CASOST (Consell Assessor per a la Sostenibilitat I el Progres del Sistema Sanitari), created to provide advice to the President of the Government of Catalonia about how the Health System should be structured.
He was the local host of the 8th International Workshop on HIV Transmission, Barcelona 4-5 October 2013 and the co-chair, together with Dr José M. Gatell and Dr. Christian Brander, of the AIDS Vaccine Conference to be held in Barcelona in October 2013, organized by the HIV Vaccine Enterprise and with HIVACAT as local host.
Dr Clotet’s team is composed by 100 people working at the clinics and at the lab focusing on HIV, hepatitis, papiloma virus and in metagenomics.